Maninder Hora

2015

In 2015, Maninder Hora earned a total compensation of $1.8M as Senior Vice President Pharmaceutical Development and Manufacturing Operations at Nektar Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$204,500
Option Awards$319,528
Salary$430,600
Stock Awards$808,594
Other$14,815
Total$1,778,037

Hora received $808.6K in stock awards, accounting for 45% of the total pay in 2015.

Hora also received $204.5K in non-equity incentive plan, $319.5K in option awards, $430.6K in salary and $14.8K in other compensation.

Rankings

In 2015, Maninder Hora's compensation ranked 5,213th out of 13,638 executives tracked by ExecPay. In other words, Hora earned more than 61.8% of executives.

ClassificationRankingPercentile
All
5,213
out of 13,638
62nd
Division
Manufacturing
1,926
out of 5,190
63rd
Major group
Chemicals And Allied Products
698
out of 1,854
62nd
Industry group
Drugs
555
out of 1,528
64th
Industry
Pharmaceutical Preparations
435
out of 1,182
63rd
Source: SEC filing on April 29, 2016.

Hora's colleagues

We found five more compensation records of executives who worked with Maninder Hora at Nektar Therapeutics in 2015.

2015

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2015

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2015

Gil Labrucherie

Nektar Therapeutics

General Counsel

2015

Ivan Gergel

Nektar Therapeutics

Chief Medical Officer

2015

Stephen Doberstein

Nektar Therapeutics

Senior Vice President and Chief Research and Development Officer

News

You may also like